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Background: Bovine BSP5 is a multifunctional protein primarily involved in sperm capacitation. BSP5 consists of
long N-terminal part followed by two similar and highly conserved fibronectin type II domains designated A and B.
Methods: In order to assess the role of these domains in the sperm binding and capacitation processes, we
created recombinant individual domains (N, A, B), series of overlapping domains (NA and AB) and full-length BSP5
in an Escherichia coli expression system. The recombinant constructs were also tested for their ability to interact
with ligands such as gelatine, heparin, chondroitin sulphate B and phosphatidylcholine liposomes by affinity
chromatography and co-sedimentation studies.
Results: With the exception of the N domain, all recombinant constructs retained gelatine, phosphatidylcholine,
heparin and chondroitin sulphate B binding activities. Domain-wise studies showed clearly that AB domain is
capable of performing its biological functions as well as the full-length protein, as it was able to potentiate
heparin-mediated sperm capacitation.
Conclusions: These results indicate that the C-terminal domain composed of two Fn2 domains is sufficient and
crucial to maintain the biological functions of BSP proteins. The N-terminal part of the protein did not bind to any
of known BSP5-ligands including epididymal sperm and did not seem to be required for either sperm binding or
sperm capacitation. This study also confirmed that glycosylation is not required for BSP-mediated sperm
capacitation or any of the binding characteristics displayed by BSP5.
Keywords: BSP5, Fibronectin type II domain, Escherichia coli expression system, Recombinant domains, Bovine
sperm, CapacitationBackground
Seminal plasma is a complex mixture of secretions from
testes, epididymides and accessory sex glands. Several
components of mammalian seminal plasma are involved
in the membrane remodeling processes occurring during
sperm maturation [1]. Among these, proteins of Binder
of SPerm (BSP) superfamily, previously called Bovine
Seminal Plasma proteins, are the most studied in terms
of biochemical properties, structure and functions [2].
The BSP proteins all have a common structure com-
posed of a variable N-terminal part followed by two tan-
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creativecommons.org/publicdomain/zero/1.0/the presence of several highly-conserved aromatic resi-
dues and four invariant cysteine residues forming intra-
domain disulfide bonds with the connectivities 1–3 and
2–4. Initially discovered in the bovine seminal plasma,
BSP protein homologs have since then been purified and
characterized from seminal plasma of boar, goat, ram,
bison, buffalo and stallion [3–9]. BSP homologous DNA
sequences have also been identified in the genomes of
human, mouse, rat, dog and chimpanzee; and BSP-like
epididymal proteins have been identified in rabbit, hu-
man and mouse [10–14].
In bovine species, three proteins BSP1, BSP3 and BSP5
(previously called PDC-109 or BSP-A1/A2, BSP-A3 and
BSP-30 kDa respectively) have been purified and bio-
chemically characterized [15, 16]. The three proteins are
glycosylated to various extents, BSP5 being the most gly-
cosylated and BSP3 having no glycosylation at all. Theyle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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interaction with choline phospholipids. Interestingly, as
opposed to BSP1 and BSP3, which binds specifically to
choline phospholipids, BSP5 has been shown to display
a broader binding specificity to lipids [17]. Some studies
performed with BSP1 demonstrated that its binding to
phosphatidylcholine (PC) liposomes and to bovine epi-
didymal sperm membrane is a very rapid, biphasic
process [18]. In the first step, the BSP protein recognizes
and interacts with the choline head group of the
phospholipid. This causes a conformational change in
the protein, which enables the penetration of short seg-
ments of the protein in the hydrophobic interior of the
membrane up to the fourteenth atom of carbon of the
phospholipid [19–21]. When BSP proteins are in low
concentrations, this interaction ultimately results in the
rigidification of the lipid phase [18, 22].
Through this interaction with phospholipids, BSP pro-
teins also play dual roles in bovine sperm capacitation, a
complex series of molecular modifications that mamma-
lian sperm must undergo before fertilizing an oocyte.
Via membrane stabilization, BSP proteins act as decapa-
citating factors. They protect sperm during their transit
through the female genital tract following ejaculation
and prevent premature sperm capacitation. Bovine BSP
proteins also promote sperm capacitation by inducing
cholesterol and phospholipid efflux from sperm [23, 24].
They can induce this efflux when they are found in high
concentrations or through interactions with high-density
lipoproteins and glycosaminoglycans (GAGs) such as
heparan sulphate found in follicular fluid [25, 26].
BSP proteins in bovine species bind to diverse ligands
such as gelatine [15], heparin [27], other GAGs [28] and
apolipoprotein A-I [29]. They also bind to components
of semen extenders namely, egg yolk-low density lipo-
proteins and major milk proteins (caseins, α-lactalbumin
and β-lactoglobulin) used for semen preservation. This
interaction is important for sperm protection [30] [31].
The mechanisms to regulate and coordinate the inter-
action of BSP proteins with diverse set of ligands in
order to accomplish function(s) are not clear. In addition
to their role in sperm capacitation, other functions have
been proposed for bovine BSPs such as the mediation of
sperm binding to the oviductal epithelium, the formation
of the sperm reservoir and the ability to prolong sperm
survival and motility in the oviduct [32, 33]. Recent
studies also reported that bovine BSP1 can function as a
molecular chaperone in vitro [34].
So far, most of the knowledge on BSP proteins has
been obtained from the study of bovine BSP1, as this
protein is found in the highest concentration in bovine
seminal plasma [35]. However, BSP5 is known to have
the longest N-terminal domain, to be the most glycosyl-
ated and to be the most active member of the bovineBSP proteins [26, 25]. Very few studies have been done
to understand if the individual domains in multi-domain
proteins such as BSP5 have ligand binding specificity
and exercise biological function(s). The importance of
the glycosylation in BSP function(s) and the minimal
functional unit required to mediate the sperm capacita-
tion are also not known.
In the current study we successfully cloned, expressed
and purified domains (N, A and B), linear combination
of domains (NA and AB) and the full length BSP5
employing Escherichia coli as host. We then analyzed
the ligand binding properties and the biological activities
of individual and overlapping recombinant domains of
bovine BSP5.
Methods
Plasmids pET32a(+) and pET30(+), Escherichia coli
strains BL21(DE3)pLysS and Origami B(DE3) and
His-bind resin were from Novagen (EMD Biosciences,
La Jolla, CA, USA). Pfu DNA polymerase was from
Fermentas (Burlington, ON, Canada) and Taq DNA
polymerase was from GE Healthcare (Baie d’Urfe, QC,
Canada). Restriction enzymes BamHI and XhoI were
from New England Biolabs (Beverly, MA, USA). QIA-
prep Spin Miniprep kit and Qiaex II gel extraction kit
were from Qiagen (Mississauga, ON, Canada). T4 DNA
ligase was from Invitrogen (Carlsbad, CA, USA). For
Western blotting, the His-probe monoclonal antibody
(H-3) was from Santa Cruz Biotechnology (Santa Cruz,
CA, USA), whereas goat anti-mouse IgG and goat anti-
rabbit IgG were from Bio-Rad (Mississauga, ON,
Canada). Chemiluminescence reagent was from Perkin-
Elmer (Boston, MA, USA). Complete Mini, EDTA-free
protease inhibitor tablets were from Roche (Manheim,
Germany). B-PER bacterial extraction reagent was from
Pierce (Rockford, IL, USA). Bovine serum albumin (BSA;
fraction V fatty acid-free), heparin (purified from porcine
intestinal mucosa), taurine, L-epinephrine, erythrosin B,
flavianic acid (naphthol), lyso-phosphatidylcholine (lyso-
PC; purified from egg yolk) were from Sigma-Aldrich
Canada (Oakville, ON, Canada). Penicillin G and
streptomycin sulphate were from Gibco (Burlington,
ON, Canada), eosin B from Fisher Scientific (Ottawa,
ON, Canada) and nigrosin from Kodak (Rochester, NY,
USA). All other chemicals used were of analytical grade
and obtained from commercial suppliers.
Construction of BSP5 expression vectors
To generate expression vectors for the production of
full-length bovine BSP5 (FL; residues 1–158), individual
domains (N, A and B) and linear combination of do-
mains (NA and AB), corresponding regions of the BSP5
gene were amplified by polymerase chain reaction using
bovine seminal vesicle cDNA as template. The amplified
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tor and expressed in E. coli BL21(DE3) cells as described
previously [36]. All the other domains were cloned in
pET32a vectors and were expressed in E. coli Origami
B(DE3) cells. As control, the empty pET32a vector was
transformed in E. coli BL21(DE3) cells to express the
thioredoxin-His-S tag (Trx-His-S).
Expression and purification
Bacteria were grown at 37 °C in Luria–Bertani medium
containing either ampicillin (100 μg/ml) or kanamycin
(50 μg/ml) until OD600nm reached ~ 0.8. Induction was
then carried out with 100 μM isopropyl-β-d-galactopyra-
noside (IPTG) at 15 °C for 16 h. For the FL protein, the
individual domains (A and B), the linear combination of
domains (NA and AB) and the Trx-His-S control, har-
vested cells were lysed by sonication in 50 mM Tris–
HCl (pH 7.9), 150 mM NaCl, 40 mM imidazole buffer,
containing 10 % B-PER (v/v), and protease inhibitor
cocktail. They were then purified by Ni-NTA affinity
chromatography according to the manufacturer’s in-
structions. Proteins were eluted from the column using
buffer containing 250 mM imidazole.
As the N-terminal part was sensitive to protease, boil-
ing lysis instead of sonication was used to purify the pro-
tein as previously described [36]. Briefly, the cell
suspension was incubated in boiling water for 20 min,
cooled on ice for 5 min, and centrifuged at 4 °C, at 15
000 rpm for 1 h. The supernatant was purified by Ni-
NTA affinity chromatography similar to the other con-
structs. The purity of each construct was examined by
SDS-PAGE. Five micrograms of each sample were sepa-
rated on a 15 % polyacrylamide gel followed by Coomassie
Brilliant Blue staining. Fractions containing purified pro-
tein were pooled, dialysed against 50 mM ammonium
bicarbonate and lyophilized.
The native BSP5 protein used as control in the experi-
ments was purified from bovine seminal plasma by
gelatine-agarose affinity chromatography as previously de-
scribed [15]. The protein estimations were done by a
modified Lowry method [37]. Lyophilized protein samples
were weighed in the microbalance (Cahn C-31) and ap-
propriate quantities were used for the subsequent studies.
Affinity chromatography
All the binding studies by affinity chromatography were
performed at 4 °C at a flow rate of 20 ml/h. For the
binding to gelatine, five hundred micrograms of the ly-
ophilized recombinant constructs and Trx-His-S were
solubilised in 5 ml of TB (Tris-Buffer; 50 mM Tris–HCl,
pH 7.4) and centrifuged 10 000 × g for 10 min to remove
any insoluble material. The supernatant were then ap-
plied on a gelatine-agarose column (bed volume of 2 ml)
previously equilibrated with TB. The column waswashed with 10 bed volumes of TB and adsorbed pro-
teins were eluted with TB containing 8 M urea.
For the binding to glycosaminoglycans, 1 mg of recom-
binant BSP5 protein constructs in 1 ml of the TB contain-
ing 40 mM NaCl was applied to a heparin-sepharose or a
chondroitin sulphate B-agarose column (bed volume,
1 ml) equilibrated in TB containing 40 mM NaCl. The
columns were washed with 10 bed volumes of the same
buffer and the adsorbed material was eluted with TB con-
taining 1 M NaCl and with the TB containing 8 M urea.
For all the chromatography assays, fractions of 1 ml were
collected and protein elution was monitored by optical
density measured at 280 nm. Proteins from each peak
were pooled, concentrated by ultrafiltration, precipitated
with 15 % trichloroacetic acid (TCA) and analyzed by
15 % SDS-PAGE followed by staining with Coomassie
Brilliant Blue.
Lipid vesicle co-sedimentation assay
Liposomes of phosphatidylcholine (PC) were prepared as
described in [17]. Briefly, 8 mg of PC (Doosan Sedary
Research Laboratories; Englewood Cliffs, NJ, USA) in
chloroform was evaporated under N2 until a thin film
was formed in the bottom of a glass tube. PC was then
resuspended in 2 ml buffer (10 mM Tris–HCl, 100 mM
KCl, pH 7.5) and the tube was sonicated in a Branson
Ultrasonic water bath (Model 3510) for ~1 min at RT
until lipids formed an opalescent suspension. Large
multi-lamellar liposomes were sedimented by ultracen-
trifugation at 100 000 × g at 25 °C for 30 min. The pellet
containing liposomes was resuspended in buffer B
(10 mM Tris–HCl, 100 mM KCl, 2.5 mM MgCl2,
pH 7.5), to obtain a final lipid concentration of 4 mg/ml.
To test the binding to PC liposomes, 20 μg of recombin-
ant BSP5 constructs, 10 μg of Trx-His-S and 10 μg of
BSP5 were incubated with liposomes (equivalent to
150 μg PC), in a total volume of 300 μl of buffer B. Incu-
bations were carried out for 30 min at RT, after which li-
posomes were centrifuged once again at 100 000 × g at
25 °C for 45 min. Equivalent fractions of supernatant
(proteins precipitated with 15 % TCA) and pellet were
analyzed by 15 % SDS-PAGE followed by Coomassie
Brilliant Blue staining and by Western blot.
Sperm binding assay
Bovine epididymides were obtained from a local slaugh-
terhouse near Montreal. Cauda sperm collected from
the epididymides were washed twice (300 × g, 10 min)
with 10 volumes of a modified Tyrode’s medium desig-
nated mTALP (100 mM NaCl, 2.7 mM KC1, 1.8 mM
CaCl2, 0.5 mM MgCl2, 0.3 mM NaH2PO4, 35.7 mM
NaHCO3, 0.1 mM sodium pyruvate, 17.4 mM sodium lac-
tate, 0.5 mM taurine, 0.05 mM L-epinephrine, 63 μg/ml
penicillin G (1585 U/mg), 0.1 mM streptomycin sulfate,
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106 cells) were then incubated in 1 ml mTALP for 90 min
at 39 °C with 20 μg/ml of respective recombinant BSP5
construct, 20 μg/ml Trx-His-S or 20 μg/ml native BSP5.
Following the incubation, sperm were pelleted at 5000 × g
for 10 min. The supernatant was removed and the pellet
was washed three times with 1 ml of PBS. The supernatant
was precipitated with TCA (15 %, final concentration), re-
suspended in Laemmli sample buffer and boiled 10 min.
The pellet was resuspended in sample buffer, boiled
10 min and sonicated 1 h in a water bath. Supernatants
and pellets were finally analyzed by western blot.
Sperm capacitation and acrosome reaction
Epididymal sperm were prepared as described above.
Washed sperm (final concentration of 5 × 107 cells/ml)
were preincubated (5 % CO2, 39 °C) for 20 min in the
presence or absence of different concentrations of each
domain constructs. Sixty μg/ml Trx-His-S and 30 μg/ml
native BSP5 were used as negative and positive control
respectively. The cells were then washed twice (300 × g,
10 min) and resuspended (final concentration of 5 × 107
cells/ml) with 12 μg/ml of heparin. After the 5 h incuba-
tion, two aliquots of each sample were taken. The first
aliquots were re-incubated for 15 min in the absence
(spontaneous acrosome reaction) or in the presence of
100 μg/ml of lyso-PC. This concentration of lyso-PC
was previously shown to induce the acrosome reaction
in capacitated sperm while having no effect on noncapa-
citated sperm [38]. The other sperm aliquots were used
for immunofluorescence study.
Staining procedure
To assess acrosome reacted status of the bovine sperm,
the naphthol yellow S-erythrosin B staining by Lenz et
al. was used [39]. Briefly, the slides were placed in 0.1 %
naphthol yellow S in 1 % aqueous acetic acid for 30 min
and rinsed in 1 % aqueous acetic acid for 10 s. The slides
were then drained, placed in a solution of 0.2 % aqueous
erythrosin B and 0.2 % naphthol yellow S (pH 4.8) for
13 min, rinsed in distilled water, and air dried.
Sperm viability
Sperm viability was estimated by the staining protocol of
Dott and Foster [40]. Briefly, an aliquot of each sperm
suspension (10 μl) was mixed with 5 μl of eosin B 5 %,
and 5 μl of a saturated solution of nigrosin was added.
The stained sperm were spread on glass slides, dried. Vi-
able (white) and non-viable (red) sperm were counted
under light microscopy in duplicate.
Immunofluorescence microscopy
Following capacitation in the presence of heparin, sperm
incubated with 60 μg/ml of respective recombinantBSP5 construct, 60 μg/ml Trx-His-S or 30 μg/ml native
BSP5 were used for immunofluorescence. Aliquot of the
sperm suspension (10 μl) were mixed with 40 μl of PBS
and 50 μl of 4 % paraformaldehyde to fix the sperm for
30 min at RT after which 450 μl of PBS were added. The
sperm were pelleted at 2000 × g for 10 min, washed with
500 μl of PBS and resuspended in a final volume of
20 μl of PBS. Two aliquots of 5 μl of the sperm suspen-
sion was applied to Poly-L-lysine slides and allowed to
dry on a slide warmer. Sperm were permeabilized for
5 min with PBS containing 0.1 % Triton-X-100 and
0.2 % paraformaldehyde, and then washed 3 times with
PBS. Nonspecific binding sites were blocked by incubat-
ing slides for 1 h at RT in PBS containing 1 % of BSA.
Slides were allowed to dry and then incubated 1 h at RT
with anti-BSP5 polyclonal antibodies or with His-probe
mouse antibodies (1:100) [16].
Slides were washed 3 times with PBS for 5 min. Slides
were allowed to dry and incubated at RT in a dark
chamber for 1 h with the secondary FITC-labelled goat
anti-rabbit IgG or secondary FITC-labelled goat anti-
mouse IgG (1:200) in PBS-0.1 % BSA. Slides were
washed 3 times for 5 min in PBS and allowed to dry.
Finally, a drop of 1.5 % DABCO (10 ml of 1,4-diazabicy-
clo[2.2.2]octane 15 % and 90 ml of glycerol) was depos-
ited on the slides. As controls for the specificity of the
immunofluorescence, sperm without any added proteins
were fixed and incubated with pre-immune sera and
FITC-labelled secondary antibodies or with FITC-
labelled secondary antibodies alone. Fluorescence was vi-
sualized with a Leica DMRE microscope, and the data
were acquired using a RETIGA EX digital camera
(QIMAGING) coupled with OpenLab 3.1.1 software
(OpenLab).
Statistical analysis
The data were analyzed for significant differences by
one-way covariance analysis followed by LSD multiple
comparison tests or by a Student t-test on paired obser-
vations using GraphPad Prism 5 software (GraphPad,
San Diego, CA, USA).
Results
Expression and purification of recombinant constructs
BSP5 is a 158 amino acid-protein composed of a highly
glycosylated N-terminal part and two Fn2 domains sepa-
rated by a 7 residues-linker (Fig. 1a). In the current
study, six different recombinant constructs were cloned
and expressed in order to analyze the ligand binding
properties and the biological activities of individual and
overlapping recombinant domains of bovine BSP5
(Fig. 1b). Cloning, expression and purification of the N-
terminal domain has already been described previously


















Thioredoxin (Trx) His6 S Domain 
C 
Fig. 1 Schematic representation of bovine BSP5 and the recombinant constructs. a Native full-length bovine BSP5 is a 158 amino acid-protein
composed of an N-terminal part and two Fn2 domains (a and b) joined by a short linker. BSP5 is glycosylated on six residues of its N-terminal
domain. b Recombinant constructs of the BSP5 proteins used in this study. c The tag encoded by the pET32a(+) expression vector consists of a
thioredoxin, followed by a (His)6-tag and a S-tag
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and is fused only to a (His)6-tag. To help with the for-
mation of the Fn2 domains and with protein refolding,
the other five constructs were expressed in pET32a ex-
pression vectors and were therefore fused with a larger
tag composed of a thioredoxin tag, a (His)6-tag and a S-
tag (Fig. 1c).
Trx-His-S tagged domains were expressed in E. coli
BL21(DE3) cells and purified by Ni2+-NTA affinity chro-
matography. All purified domains were then analyzed by
SDS-PAGE on 15 % polyacrylamide gels stained with
Coomassie Brilliant Blue. Constructs were more than
90 % pure (Fig. 2). The two controls, Trx-His-S and na-
tive BSP5, were shown to have similar levels of purity.Recombinant constructs N, A, B, NA, AB and FL were
found to have apparent molecular weights of approxi-
mately 24, 29, 29, 32, 39 and 42 kDa respectively as previ-
ously reported. Identity of the constructs was also
confirmed by Western blot using anti-BSP5 polyclonal
antibodies or His-probe monoclonal antibody (not shown).
Binding properties
Interaction of the recombinant constructs with gelatine,
heparin and chondroitin sulfate B (CSB) was tested by
affinity chromatography (Table 1). When less than five
percent of the proteins were found in the adsorbed frac-
tion, binding was considered as non-specific as was the








N         A       B       NA    AB       FL    Trx   BSP5
Fig. 2 SDS-PAGE pattern of purified BSP5 recombinant constructs.
pET32a(+) constructs of full length (FL), A domain (A); B domain (B);
NA domain (NA) and (AB) domain were expressed in E. coli
origami(DE3) cells and purified by Ni2+-NTA affinity chromatography.
The pET30a(+) N-terminal (N) construct was expressed in E. coli
BL21(DE3) cells. Five micrograms of purified proteins were analyzed
by 15 % SDS-PAGE followed by Coomassie Blue staining
Table 2 Summary of binding studies of recombinant BSP5
constructs to PC-liposomes and epididymal sperm by co-
sedimentation








(−) No binding, (+) Binding observed
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act with the ligands with varying affinities. As was previ-
ously observed for the native BSP5, the FL construct
displayed a strong affinity for both gelatine and GAGs.
Similar results were obtained with domains B and AB. In
the case of domains A and NA, they showed strong affin-
ity for heparin and CSB, but a slightly higher amount of
proteins were found in the unabsorbed fraction.
Co-sedimentation was used to test the interaction of
recombinant constructs with both PC liposomes and bo-
vine epididymal sperm (Table 2). Binding was scored fol-
lowing SDS-PAGE and western blot when a band
corresponding to the recombinant domain was visible in
the pellet fraction containing the liposomes or epididy-
mal sperm. Based on these criteria, similar results were
obtained for binding to PC liposomes and to epididymal
bovine sperm. All domains with the exception of N-
domain were found to interact with PC liposomes and
epididymal sperm. Trx-His-S and N-domain were only
found in the supernatant fraction suggesting a lack ofTable 1 Summary of binding studies of recombinant BSP5
constructs by affinity chromatography
Constructs Gelatine Heparin Chondroitin Sulfate B
N - - -
A ++ ++++ +++
B +++ +++ +++
NA ++ ++++ +++
AB +++ ++++ +++
FL +++ +++ ++++
Trx-His-S - - -
(−) <5 % binding, (+) 5-25 %, (++) 26-50 %, (+++) 51-75 %, (++++) 76-100 %interaction. As control, recombinant domains were also
incubated in the absence of liposomes and centrifuged.
Under those conditions, all domains were found in the
supernatant fraction only (data not shown).Heparin-induced capacitation assay
To examine whether the recombinant constructs of
BSP5 were able to mediate heparin sperm capacitation,
capacitation assays were carried out with different con-
centrations of the constructs, native BSP5 serving as
positive control and Trx-His-S as negative control. Cap-
acitation was assessed by the ability of sperm to undergo
the AR induced by lyso-PC. Recombinant domains N, A,
B and NA did not cause any significant increase in the
percentage of acrosome reaction observed following in-
cubation of sperm in the presence of lyso-PC (Fig. 3a-d;
white bars). Increasing concentrations of the recombin-
ant AB and FL constructs however caused a significant
dose-dependent increase in the percentage of sperm ac-
rosome reaction induced by lyso-PC, with a protein con-
centration as low as 5 μg/ml. Results obtained with AB
and FL constructs were comparable to those to the na-
tive BSP5 positive control (Fig. 3e-f; white bars). Recom-
binant domains did not affect spontaneous acrosome
reaction (without induction by lyso-PC), as after 5 h in-
cubation with different domains, levels of acrosome re-
action were equivalent to that of sperm incubated with
media alone (Fig. 3; black bars).Sperm viability
During the capacitation studies, the effect of recombin-
ant proteins on sperm viability was also evaluated. None
of the recombinant constructs including Trx-His-S af-
fected the viability of the sperm (Fig. 4). At the begin-
ning of the incubation with heparin approximately 75 %
of sperm were viable. A slight decrease was observed to-
ward the end of the incubation, but this effect was
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Fig. 3 Effect of recombinant BSP5 constructs on lyso-PC-induced acrosome reaction of epididymal sperm incubated with heparin. Sperm
collected from cauda epididymis were incubated for 20 min alone or in media containing increasing concentrations of the different BSP5
constructs, 60 μg/ml Trx-His-S or 30 μg/ml native BSP5. Sperm were then washed, incubated with 12 μg/ml of heparin for 5 h and incubated an
additional 15 min in presence (white bars) or absence (black bars) of 100 μg/ml lyso-PC. Acrosome reaction was assessed by naphtol yellow
S-erythrosin B staining. Data are presented as the mean ± SD of three independent experiments. Differences compared to control (no proteins
added) were analyzed by one-way covariance analysis followed by LSD multiple comparison tests (* p < 0.05). Panels (a-f) correspond respectively
to Domain N, Domain A, Domain B, Domain NA, Domain AB and Protein FL (Full length)
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bovine epididymal sperm
Binding of constructs to epididymal sperm was also con-
firmed by immunolocalization studies as signals were
observed on epididymal sperm for all recombinant con-
structs except the N-terminal domain. As reported previ-
ously, the positive control, native BSP5, bound to more
than 95 % of the epididymal sperm cells [41]. Recombinant
constructs AB and FL were found at the surface of ~50 %
of the epididymal sperm. The other domains A, B and NA
were also detected on sperm surface, but on fewer sperm(Not shown). The intensity of the signal for domains A and
B was also weaker.
To determine if the recombinant constructs and native
BSP5 protein remain bound to sperm after capacitation
processes, aliquots of sperm were taken at the end of the
capacitation prior to the incubation with lyso-PC and
evaluated by immunofluorescence (Fig. 5). Patterns ob-
served were similar to those observed in non-capacitated
conditions indicating that proteins were still present,
and that localization of the domains on sperm surface























40 µg/ml 60 µg/ml 30 µg/ml 
Fig. 4 Effect of recombinant BSP5 constructs on the viability of
epididymal sperm incubated with heparin. Sperm collected from
epididymis were incubated for 20 min alone or in media containing
40 μg/ml of constructs N, A and B, 60 μg/ml of constructs NA, AB
and FL, 60 μg/ml Trx-His-S or 30 μg/ml native BSP5. Sperm were
then washed, incubated with 12 μg/ml of heparin for 5 h. Viability
was assessed by staining with eosin/nigrosin solutions. Data are
presented as the mean ± SD of three independent experiments
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the binding of native BSP5, was not restricted to head
portion of the sperm as proteins were also localized to the
midpiece of the sperm. No signal was obtained when
sperm were incubated without protein (control) or with
Trx-His-S using His-probe antibody as primary antibody.
Discussion
Bovine BSP proteins are multifunctional proteins, via
their interaction with cell membranes and with proteins
such as GAGs. Heparan sulfate and other GAGs like
heparin and chondroitin sulphate B are present in ovi-
ductal and follicular fluids of bovine species [28]. Since
heparin is commonly used to induce the sperm capacita-
tion in bovine species [26], it was of interest to check if
the recombinant BSP5 protein constructs could bind to
heparin and chondroitin sulphate B. It is not surprising
that the N-terminal part of the protein did not show any
interaction with the GAGs, as this domain is rich in
negatively charged amino acids and does not contain the
known heparin binding-consensus sequences B-B-X-B or
B-X-X-B-X-B-B (where B represent basic residues and X
represents any residues) [42, 27]. All the other recom-
binant constructs displayed expected binding characters
with respect to heparin and chondroitin sulphate B. Re-
sults seem to suggest that glycosylation is not essential
for the binding of bovine BSP proteins to heparin or
chondroitin sulphate B. These results contradict the ob-
servation reported for porcine and equine BSP proteins.
In these species, it seems that glycosylation can modu-
late the aggregation state of the BSP proteins and thushas an indirect effect on the ability of these proteins to
bind to heparin [43].
Although gelatine binding is a characteristic feature of
Fn2 domains, the biological relevance of this property in
bovine BSP proteins is not known. Of all the domains
tested in the current study, only the N-terminal domain
failed to interact with gelatine. Results obtained are in
accordance with previous experiments performed with
BSP1 B domain isolated by tryptic digestion [44]. Inter-
estingly, results seem to suggest that B domain has a
greater affinity than domain A, even with the presence
of the N terminal part in the NA construct. This slightly
lower affinity of A and NA constructs could possibly be
due to the presence of a phenylalanine residue in pos-
ition 108 of the BSP5 protein sequence. Indeed some
previous studies on the structure of Fn2 domains have
shown that a tyrosine residue in this position is neces-
sary for strong gelatine binding [45].
As expected, A, B, NA, AB and FL constructs, which
contain one or two Fn2 domains, interacted with PC li-
posomes. This is in agreement with the established fact
that the Fn2 domains are responsible for the binding to
PC groups [46, 20]. The PC ligand binding is mediated
by a cation- π interaction between the quaternary am-
monium group of the choline moiety and the indole ring
of a core tryptophan residue, and hydrogen bonding be-
tween the phosphate group and exposed tyrosine resi-
dues of the BSP proteins [20]. In contrast, the negatively
charged N-terminal part did not interact with neutral
lipid PC. As BSP proteins bind to sperm via an inter-
action with choline phospholipids, all recombinant do-
mains interacting with PC liposomes also bound to
bovine epididymal sperm.
In this study, we also demonstrated for the first time
that the native BSP5 protein and all recombinant con-
structs, except the N domain, remained associated with
sperm even after heparin-mediated capacitation. These
results are in contradiction with the work previously
published by Hung et al., who observed a complete loss
of BSP5 on sperm surface following 5 h-incubations in
the presence and absence of heparin [47]. This discrep-
ancy could be due to the different antibody used in each
study. Hung et al., used an antibody against an N-
terminal peptide of the BSP5 protein, whereas the anti-
body used in the current study was prepared against the
full-length native BSP5 protein. This difference between
studies could suggest, that during sperm capacitation or
during prolonged incubation, BSP5 is not lost, but is
partly cleaved or modified at its N-terminal part.
After binding studies, the recombinant domains were
tested for their ability to induce heparin-mediated sperm
capacitation. As mentioned previously, the acrosome re-
action induced by lyso-PC in the present context is













Fig. 5 Immunostaining of recombinant BSP5 constructs on heparin-capacitated sperm. Sperm from cauda epididymis were incubated 20 min
alone (Ctrl) or in media containing 60 μg/ml of each construct, 60 μg/ml Trx-His-S or 30 μg/ml native BSP5. Sperm were then washed and
incubated for 5 h with 12 μg/ml of heparin. Aliquots of the samples were dried on poly-L-lysine slides. Slides were then incubated with anti-BSP5
or His-probe (Trx-His-S slide) antibodies at dilution of 1:100 and treated with FITC-conjugated IgG. (Original magnification × 630; DIC, Differential
Interference Contrast)
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to the level comparable to native BSP5 protein. The re-
combinant A, B, NA and N domains and the control
Trx-His-S construct did not have any effect on the
sperm capacitation mediated by heparin. These results
are in agreement with results obtained by Moreau et al.,
showing that the B domain of BSP1 is not sufficient to
stimulate sperm cholesterol efflux associated with cap-
acitation [44]. Since there is no difference in stimulation
in the level of sperm capacitation observed in presence
of the AB construct versus the full-length construct, it
seems that the N-terminal part does not appear to playrole in sperm capacitation. Similar functional mapping
studies on the human ZP3, which acts as a primary
sperm receptor, have concluded that the functional ac-
tivity of the protein resides in its C-terminal domain
[48]. Similar functional mapping studies of sperm pro-
teins have also been used to define parts of proteins,
which could be used as contraceptive antigen [49].
As reported previously for experiments with the native
BSP5 protein [26], the spontaneous acrosome reaction
remained low in the presence of all recombinant con-
structs. This suggests that similar to the native BSP5
protein, the recombinant constructs cannot stimulate
Jois et al. Reproductive Biology and Endocrinology  (2015) 13:64 Page 10 of 11the acrosome reaction by themselves, and induction by
lyso-PC is essential for stimulation of the acrosome reac-
tion of capacitated sperm. All these results tend to dem-
onstrate that the domains A and B together constitute
the minimal functional unit for sperm capacitation in-
duced by heparin. Since recombinant protein constructs
were expressed in E. coli, it became evident that glyco-
sylation is not required for BSP binding to sperm or for
its function in heparin-induced capacitation. It is there-
fore possible that the glycosylation of BSP proteins is
not required for them to perform their function, but
could play other roles. For example, mouse sperm pro-
tein IZUMO, a protein essential for sperm fusion with
eggs, glycosylation is not required for the function but
has a protective role [50].
Conclusions
In conclusion, this study demonstrates that two tandem
fibronectin domains at the C-terminus part of the pro-
tein are sufficient to mediate the sperm capacitation in
bovine BSP5. The N-terminal part and glycosylation
have no direct role in mediating sperm binding or cap-
acitation or acrosome reaction. As the modular structure
of BSP proteins is highly conserved among mammals,
these results could be extended to other members of
BSP superfamily. The function of N-terminal part still
remains elusive. BSP proteins were discovered three de-
cades ago, some new functions have been proposed in
the recent years for these proteins. It will be interesting,
to know, if the N-terminal part of the BSP proteins and/
or its glycosylation is important for these new functions.
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